Immix Biopharma (IMMX) Payables (2020 - 2026)
Immix Biopharma's (IMMX) quarterly Payables came in at $193715.0 in Q1 2026, up 52.09% year-on-year from $127367.0 in Q1 2025, and down 96.44% quarter-over-quarter from $5.4 million in Q4 2025.
Immix Biopharma (IMMX) Payables (2020 - 2026) Analysis & Trends
Immix Biopharma has disclosed Payables across 7 years of filings, most recently posting $193715.0 for Q1 2026.
- Payables for Q1 2026 came in at $193715.0, up 52.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $193715.0 (up 52.09% YoY), and the FY2025 annual result was $5.4 million, up 4100.71% from the prior year.
- Payables came in at $193715.0 for Q1 2026 at Immix Biopharma, down from $5.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $6.6 million in Q2 2025 to a low of $122594.0 in Q1 2024.
- The 5-year median for Payables is $1.3 million (2022), against an average of $2.2 million.
- Peak annual rise in Payables reached 4100.71% in 2025, while the deepest fall reached 97.37% in 2025.
- Immix Biopharma's Payables stood at $1.3 million in 2022, then soared by 192.3% to $3.7 million in 2023, then sank by 96.52% to $129567.0 in 2024, then jumped by 4100.71% to $5.4 million in 2025, then plunged by 96.44% to $193715.0 in 2026.
- The last three Payables figures came in at $193715.0 (Q1 2026), $5.4 million (Q4 2025), and $170896.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 34.55 Mn |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | 193,715.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193,715.00 |
| Dec 31, 2025 | 5.44 Mn |
| Sep 30, 2025 | 170,896.00 |
| Jun 30, 2025 | 6.61 Mn |
| Mar 31, 2025 | 127,367.00 |
| Dec 31, 2024 | 129,567.00 |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 3.85 Mn |
| Mar 31, 2024 | 122,594.00 |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 646,457.00 |
| Jun 30, 2022 | 977,209.00 |
| Mar 31, 2022 | 355,679.00 |
| Dec 31, 2021 | 192,940.00 |
| Dec 31, 2020 | 302,344.00 |